Journal of Oncology Practice, Vol 5, No 2 (March), 2009: pp. 76-79
© 2009
American Society of Clinical Oncology.
DOI: 10.1200/JOP.0924602
Cost-Neutral Clinical Research Enterprise
| Because this article has no abstract, we have provided an extract of the first 100 words of the full text.
|
This article is the fifth in a continuing series of articles focusing on the exemplary attributes of successful research in clinical practice. ASCO described a core group of standards and exemplary attributes of clinical trial sites in the initial article of the series in May 2008.1 This article addresses the challenge of creating a research program that at minimum will be self-supporting. Two attributes of a cost-neutral clinical research enterprise are diversification of trial mix and high accrual activity.
 |
Background
|
|---|
Mature, established, exemplary clinical trial sites have a broad, diversified portfolio of clinical trials offered, which in the words of the . . . [Click for More]

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
|